Sectors
RXRX
Recursion Pharmaceuticals, Inc.
3.31
17 x 3.29
40 x 3.30
bid
ask
+
0.02
0.47%
09:39 AM
timesize
| Ytd | -19.18% | |
| 1y | -37.52% |
3.28
day range
3.35
2.77
52 week range
7.18
| Open | 3.31 | Prev Close | 3.29 | Low | 3.28 | High | 3.35 | Mkt Cap | 1.73B |
| Vol | 1.09M | Avg Vol | 20.94M | EPS | -1.04 | P/E | -3.16 | Forward P/E | -3.53 |
| Beta | 1.03 | Short Ratio | 7.68 | Inst. Own | 72.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.31 | 200-d Avg | 3.82 | 1yr Est | 7.25 |
| Income Statement | |||
| Total Revenue | 7.67M | ||
| Revenues (USD) | 7.67M | ||
| Cost of Revenue | 11.49M | ||
| Gross Profit | -3.82M | ||
| Operating Expenses | 131.15M | ||
| Research and Development Expense | 89.61M | ||
| Selling, General and Administrative Expense | 41.53M | ||
| Operating Income | -134.97M | ||
| Income Tax Expense | -1000 | ||
| Net Income | -131.00M | ||
| Net Income Common Stock | -131.00M | ||
| Net Income Common Stock (USD) | -131.00M | ||
| Consolidated Income | -131.00M | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -131.01M | ||
| Earning Before Interest & Taxes (USD) | -131.01M | ||
| Weighted Average Shares | 532.46M | ||
| Weighted Average Shares Diluted | 532.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 551.07M | ||
| Cash and Equivalents (USD) | 551.07M | ||
| Investments | 5.75M | ||
| Investments Non-Current | 5.75M | ||
| Trade and Non-Trade Receivables | 14.39M | ||
| Current Assets | 603.46M | ||
| Property, Plant & Equipment Net | 147.07M | ||
| Total Assets | 1.21B | ||
| Debt Current | 22.69M | ||
| Total Debt | 66.64M | ||
| Current Liabilities | 119.89M | ||
| Debt Non-Current | 43.95M | ||
| Total Liabilities | 297.67M | ||
| Accumulated Retained Earnings (Deficit) | -2.32B | ||
| Accumulated Other Comprehensive Income | 27.99M | ||
| Shareholders Equity | 915.00M | ||
| Shareholders Equity (USD) | 915.00M | ||
| Assets Non-Current | 609.21M | ||
| Total Debt (USD) | 66.64M | ||
| Deferred Revenue | 140.40M | ||
| Goodwill and Intangible Assets | 443.24M | ||
| Liabilities Non-Current | 177.78M | ||
| Trade and Non-Trade Payables | 12.67M | ||
| Tax Assets | 957.00K | ||
| Tax Liabilities | 18.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.38M | ||
| Net Cash Flow from Financing | -1.27M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -108.36M | ||
| Capital Expenditure | -44.00K | ||
| Issuance (Purchase) of Equity Shares | 984.00K | ||
| Issuance (Repayment) of Debt Securities | -2.25M | ||
| Net Cash Flow from Investing | -1.96M | ||
| Net Cash Flow from Operations | -105.95M | ||
| Effect of Exchange Rate Changes on Cash | 813.00K | ||
| Share Based Compensation | 19.50M | ||